Update of recent clinical trials in heart failure and myocardial infarction

This publication has 11 references indexed in Scilit:

• The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial
  The Lancet, 1999
• A Dose-Dependent Increase in Mortality with Vesnarinone among Patients with Severe Heart Failure
  New England Journal of Medicine, 1998
• Neurohormonal Activation in the Treatment of Congestive Heart Failure: Basis for New Treatments?
  Cardiology, 1998
• Rationale, Design, and Organization of the Metoprolol CR/XL Randomized Intervention Trial in Heart Failure (MERIT-HF)
  The American Journal of Cardiology, 1997
• The design of the mortality assessment in congestive heart failure trial (MACH-1, Mibefradil)
  Clinical Cardiology, 1997
• Design of the cardiac insufficiency bisoprolol study II (OBIS II)
  Fundamental & Clinical Pharmacology, 1997
• Effectiveness of Spironolactone Added to an Angiotensin-Converting Enzyme Inhibitor and a Loop Diuretic for Severe Chronic Congestive Heart Failure (The Randomized Aldactone Evaluation Study [RALES])**See Appendix for full list of RALES investigators.
  The American Journal of Cardiology, 1996
• Current Guidelines for the Treatment of Congestive Heart Failure
  Drugs, 1996
• Overview of Randomized Trials of Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Patients With Heart Failure
  JAMA, 1995
• Preliminary results of the Cardiac Arrest Study Hamburg (CASH)
  The American Journal of Cardiology, 1993